Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4111815 | 1.00 | MEN1 (0.38) | MEN1KMT2AEPHX2ALDH1A1TSHR | |
| Iodide SCHEMBL30108898 | 0.98 | MEN1 (0.37) | MEN1KMT2AEPHX2ALDH1A1TSHR | |
| Bromide SCHEMBL30108899 | 0.98 | MEN1 (0.37) | MEN1KMT2AEPHX2ALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL667504 | 0.98 | MEN1 (0.37) | MEN1KMT2AEPHX2ALDH1A1TSHR | |
| SCHEMBL1427853 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL4966370 | 0.94 | ALDH1A1 (0.37) | MEN1KMT2AEPHX2ALDH1A1TSHR | |
| Sulfuric Acid SCHEMBL11367004 | 0.86 | ALOX15 (0.46) | MEN1KMT2AEPHX2ALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL29707861 | 0.83 | MEN1 (0.33) | MEN1KMT2AEPHX2ALDH1A1THRB | |
| SCHEMBL4094463 | 0.83 | MEN1 (0.38) | MEN1KMT2AEPHX2ALDH1A1TSHR | |
| SCHEMBL4103962 | 0.83 | TSHR (0.47) | MEN1KMT2AALDH1A1TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025056500-A1 | FATTY ACID SALT | ONOS TECHNOLOGIES HOLDING LIMITED (IE) | 2025-03-20 | — | — | WO | claimed |
| EP-2934480-B1 | GERMICIDAL COMPOSITIONS COMPRISING CARBOXYLIC ACID MIXTURE AND USE AS TOPICAL DISINFECTANTS | DELAVAL HOLDING AB (SE) | 2023-05-24 | — | — | EP | claimed |
| EP-3313183-B1 | AN AQUEOUS ANTIMICROBIAL FILM-FORMING COMPOSITION FOR TEAT TREATMENT BY SPRAY APPLICATION | ECOLAB USA INC (US) | 2020-07-08 | — | — | EP | claimed |
| WO-2025056500-A1 | FATTY ACID SALT | ONOS TECHNOLOGIES HOLDING LIMITED (IE) | 2025-03-20 | — | — | WO | disclosed |
| US-12161764-B2 | Composition and methods of treatment | BLUEBERRY THERAPEUTICS LIMITED (GB) | 2024-12-10 | — | — | US | disclosed |
| CN-116726232-A | Guanidine antibacterial blood coagulation gauze and preparation method thereof | 上海立宝医疗科技有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-115216854-B | Environment-friendly antibacterial ganoderma lucidum fiber and preparation method thereof | 李庆生 | 2023-08-15 | — | — | CN | disclosed |
| CN-115216854-A | Environment-friendly antibacterial ganoderma lucidum fiber and preparation method thereof | 李庆生 | 2022-10-21 | — | — | CN | disclosed |
| US-20220133640-A1 | COMPOSITION AND METHODS OF TREATMENT | BLUEBERRY THERAPEUTICS LTD (GB) | 2022-05-05 | — | — | US | disclosed |
| US-8772341-B2 | Compositions for the treatment of hoof diseases | DELAVAL HOLDING AB (SE) | 2014-07-08 | — | — | US | disclosed |
| US-8569373-B2 | Compositions comprising A C2-C14 carboxylic acid and a surfactant for treating hoof diseases | DELAVAL HOLDING AB (SE) | 2013-10-29 | — | — | US | disclosed |
| US-20100234460-A1 | Compositions Comprising A C2-C14 Carboxylic Acid And A Surfactant For Treating Hoof Diseases | DELAVAL HOLDINGS AB (SE) | 2010-09-16 | — | — | US | disclosed |
| US-20090194124-A1 | Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine | MALLE GERARD | 2009-08-06 | — | — | US | disclosed |
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | L'OREAL S.A. | 2009-06-04 | — | — | US | disclosed |
| EP-1597302-A1 | POLYMER GUANIDINE DERIVATIVES AS A CYTOSTATIC MEDICAMENT | Geopharma ProduktionsGMBH (AU) | 2005-11-23 | — | — | EP | disclosed |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | L'OREAL S.A. (FR) | 2005-06-23 | — | — | US | disclosed |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | L'OREAL | 2005-06-16 | — | — | US | disclosed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004069898-A1 | POLYMER GUANIDINE DERIVATIVES AS A CYTOSTATIC MEDICAMENT | GEOPHARMA PRODUKTIONSGMBH (AT) | 2004-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12161764-B2 | Composition and methods of treatment | POLR1C, PIK3C3, DPM1 | MEN1 1832/4885KMT2A 1985/4885EPHX2 4454/4885 |
| US-20220133640-A1 | COMPOSITION AND METHODS OF TREATMENT | POLR1C, PIK3C3, DPM1 | MEN1 1832/4885KMT2A 1985/4885EPHX2 4454/4885 |
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | KRT18, INMT, INHA | MEN1 261/4885KMT2A 322/4885EPHX2 3781/4885 |
| US-20090194124-A1 | Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine | KRT18, KIT, PRDM7 | MEN1 294/4885KMT2A 555/4885EPHX2 2648/4885 |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | KRT18, INHA, H1-5 | MEN1 237/4885KMT2A 949/4885EPHX2 2936/4885 |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | BHMT, KRT18, INMT | MEN1 455/4885KMT2A 665/4885EPHX2 3448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.